{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:52:58Z","timestamp":1793505178270,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.vascn.2017.04.013","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T12:47:01Z","timestamp":1493470021000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"P1","title":["Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons"],"prefix":"10.1016","volume":"88","author":[{"given":"Sabine","family":"Pellett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Tepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Sesardic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2017.04.013_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/026119291003800401","article-title":"The current scientific and legal status of alternative methods to the LD50 test for botulinum neurotoxin potency testing. The report and recommendations of a ZEBET Expert Meeting","volume":"38","author":"Adler","year":"2010","journal-title":"Alternatives to Laboratory Animals: ATLA"},{"key":"10.1016\/j.vascn.2017.04.013_bb0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mib.2012.05.012","article-title":"Clinical applications of botulinum toxin","volume":"15","author":"Dressler","year":"2012","journal-title":"Current Opinion in Microbiology"},{"issue":"Pt 10","key":"10.1016\/j.vascn.2017.04.013_bb0015","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1099\/00221287-143-10-3337","article-title":"Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro","volume":"143","author":"Ekong","year":"1997","journal-title":"Microbiology"},{"key":"10.1016\/j.vascn.2017.04.013_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049516","article-title":"Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay","volume":"Vol. 7","author":"Fernandez-Salas","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.vascn.2017.04.013_bb0025","series-title":"Laboratory diagnosis of infectious diseases: Principles and practice","first-page":"111","article-title":"Botulism","volume":"Vol. 1","author":"Hatheway","year":"1988"},{"key":"10.1016\/j.vascn.2017.04.013_bb0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2202-13-127","article-title":"High yield derivation of enriched glutamatergic neurons from suspension-cultured mouse ESCs for neurotoxicology research","volume":"Vol. 13","author":"Hubbard","year":"2012","journal-title":"BMC Neuroscience"},{"key":"10.1016\/j.vascn.2017.04.013_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jim.2007.09.014","article-title":"Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins","volume":"329","author":"Jones","year":"2008","journal-title":"Journal of Immunological Methods"},{"key":"10.1016\/j.vascn.2017.04.013_bb0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/14737159.2014.867808","article-title":"Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery","volume":"14","author":"Kiris","year":"2014","journal-title":"Expert Review of Molecular Diagnostics"},{"key":"10.1016\/j.vascn.2017.04.013_bb0045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ab.2012.02.038","article-title":"A functional dual-coated (FDC) microtitre plate method to replace the botulinum toxin LD(50) test","volume":"425","author":"Liu","year":"2012","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.vascn.2017.04.013_bb0050","first-page":"27","article-title":"Purification of Clostridium botulinum type A neurotoxin","volume":"145","author":"Malizio","year":"2000","journal-title":"Methods in Molecular Biology (Clifton, N.J.)"},{"key":"10.1016\/j.vascn.2017.04.013_bb0055","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1087057109354779","article-title":"Development of cell-based assays to measure botulinum neurotoxin serotype A activity using cleavage-sensitive antibodies","volume":"15","author":"Nuss","year":"2010","journal-title":"Journal of Biomolecular Screening: The Official Journal of the Society for Biomolecular Screening"},{"key":"10.1016\/j.vascn.2017.04.013_bb0060","first-page":"257","article-title":"Progress in cell based assays for botulinum neurotoxin detection","volume":"364","author":"Pellett","year":"2013","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"10.1016\/j.vascn.2017.04.013_bb0065","doi-asserted-by":"crossref","first-page":"14566","DOI":"10.1038\/srep14566","article-title":"Human induced pluripotent stem cell derived neuronal cells cultured on chemically-defined hydrogels for sensitive in vitro detection of botulinum neurotoxin","volume":"5","author":"Pellett","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2017.04.013_bb0070","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1016\/j.febslet.2007.08.078","article-title":"A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies","volume":"581","author":"Pellett","year":"2007","journal-title":"FEBS Letters"},{"key":"10.1016\/j.vascn.2017.04.013_bb0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.vascn.2010.01.003","article-title":"Comparison of the primary rat spinal cord cell (RSC) assay and the mouse bioassay for botulinum neurotoxin type A potency determination","volume":"61","author":"Pellett","year":"2010","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2017.04.013_bb0080","first-page":"96","article-title":"Standardized assay for Clostridium botulinum toxins","volume":"61","author":"Schantz","year":"1978","journal-title":"Journal of the Association of Official Analytical Chemists"},{"key":"10.1016\/j.vascn.2017.04.013_bb0085","series-title":"Alternatives to the LD50 assay for botulinum toxin potency testing: Strategies and progress towards refinement, reduction and replacement Special Issue","first-page":"581","volume":"Vol. 14","author":"Sesardic","year":"2007"},{"key":"10.1016\/j.vascn.2017.04.013_bb0090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/toxsci\/kfr354","article-title":"Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection","volume":"126","author":"Whitemarsh","year":"2012","journal-title":"Toxicological Sciences: An Official Journal of the Society of Toxicology"},{"key":"10.1016\/j.vascn.2017.04.013_bb0095","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1128\/IAI.00536-13","article-title":"Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, neuronal cell cultures, and in vitro","volume":"81","author":"Whitemarsh","year":"2013","journal-title":"Infection and Immunity"},{"issue":"3\/4","key":"10.1016\/j.vascn.2017.04.013_bb0100","first-page":"360","article-title":"Biologically relevant alternative cell-based sandwich-ELISA assay for detection and quantification of botulinum toxins","volume":"2","author":"Yadirgi","year":"2013","journal-title":"The Botulinum J."}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871917300692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871917300692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:28Z","timestamp":1761004828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871917300692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":20,"alternative-id":["S1056871917300692"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2017.04.013","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2017.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}